Industry Groups Promote Supply Chain ‘Mapping’ to Prioritize Risks

Drugmakers can help secure the global supply chain from counterfeits and cargo theft by mapping their network of suppliers to better assess their risks and prioritize mitigation, industry groups say. As a first step, drugmakers should catalogue each third-party provider and visualize the paths of product movement between facilities, the pharma industry consortium Rx360 recommends in a newly published white paper.
Washington Drug Letter